Stifel Nicolaus Boosts Trupanion (NASDAQ:TRUP) Price Target to $40.00

Trupanion (NASDAQ:TRUP) had its price target increased by Stifel Nicolaus from $30.00 to $40.00 in a research report sent to investors on Monday, Benzinga reports. Stifel Nicolaus currently has a hold rating on the financial services provider’s stock.

A number of other equities research analysts have also issued reports on the company. Bank of America raised their price target on Trupanion from $47.00 to $56.00 and gave the stock a buy rating in a research note on Friday, September 20th. William Blair started coverage on Trupanion in a research note on Friday, July 19th. They set an outperform rating for the company. Piper Sandler raised their price target on Trupanion from $30.00 to $38.00 and gave the stock a neutral rating in a research note on Friday, August 9th. Northland Securities raised their price target on Trupanion from $35.00 to $45.00 and gave the stock a market perform rating in a research note on Thursday, September 19th. Finally, Evercore ISI raised Trupanion to a strong-buy rating in a research note on Friday, August 9th. Four equities research analysts have rated the stock with a hold rating, three have assigned a buy rating and one has assigned a strong buy rating to the stock. According to MarketBeat, the company presently has an average rating of Moderate Buy and an average price target of $40.67.

Trupanion Stock Down 0.7 %

Shares of TRUP opened at $42.05 on Monday. The business’s 50 day moving average is $41.04 and its 200 day moving average is $32.00. The company has a market capitalization of $1.77 billion, a PE ratio of -65.70 and a beta of 1.74. Trupanion has a 12-month low of $19.14 and a 12-month high of $49.14. The company has a current ratio of 1.63, a quick ratio of 1.63 and a debt-to-equity ratio of 0.42.

Trupanion (NASDAQ:TRUP) last released its quarterly earnings results on Thursday, August 8th. The financial services provider reported ($0.14) earnings per share for the quarter, beating the consensus estimate of ($0.18) by $0.04. The business had revenue of $314.80 million during the quarter, compared to analysts’ expectations of $309.33 million. Trupanion had a negative return on equity of 6.29% and a negative net margin of 1.57%. The firm’s revenue for the quarter was up 16.3% compared to the same quarter last year. During the same quarter last year, the business posted ($0.33) EPS. Research analysts expect that Trupanion will post -0.34 earnings per share for the current fiscal year.

Insider Activity

In other news, CEO Margaret Tooth sold 7,500 shares of the company’s stock in a transaction that occurred on Wednesday, August 28th. The stock was sold at an average price of $46.48, for a total value of $348,600.00. Following the completion of the sale, the chief executive officer now directly owns 99,984 shares in the company, valued at $4,647,256.32. The transaction was disclosed in a document filed with the Securities & Exchange Commission, which is available through the SEC website. In related news, CEO Margaret Tooth sold 7,500 shares of the stock in a transaction that occurred on Wednesday, August 28th. The stock was sold at an average price of $46.48, for a total value of $348,600.00. Following the completion of the transaction, the chief executive officer now directly owns 99,984 shares in the company, valued at $4,647,256.32. The sale was disclosed in a document filed with the Securities & Exchange Commission, which is available at this hyperlink. Also, CFO Fawwad Qureshi sold 624 shares of the firm’s stock in a transaction on Monday, August 26th. The stock was sold at an average price of $46.54, for a total value of $29,040.96. The disclosure for this sale can be found here. Insiders sold 8,764 shares of company stock worth $405,238 over the last ninety days. Corporate insiders own 5.50% of the company’s stock.

Institutional Trading of Trupanion

A number of hedge funds and other institutional investors have recently bought and sold shares of the business. Vanguard Group Inc. increased its position in shares of Trupanion by 0.9% during the first quarter. Vanguard Group Inc. now owns 3,673,791 shares of the financial services provider’s stock worth $101,433,000 after purchasing an additional 32,485 shares in the last quarter. Wellington Management Group LLP increased its position in shares of Trupanion by 34.6% during the fourth quarter. Wellington Management Group LLP now owns 2,453,685 shares of the financial services provider’s stock worth $74,862,000 after purchasing an additional 630,155 shares in the last quarter. 8 Knots Management LLC increased its position in shares of Trupanion by 87.0% during the first quarter. 8 Knots Management LLC now owns 1,297,485 shares of the financial services provider’s stock worth $35,824,000 after purchasing an additional 603,775 shares in the last quarter. Marshall Wace LLP increased its position in shares of Trupanion by 11.9% during the second quarter. Marshall Wace LLP now owns 1,094,589 shares of the financial services provider’s stock worth $32,181,000 after purchasing an additional 116,496 shares in the last quarter. Finally, Sivia Capital Partners LLC acquired a new stake in shares of Trupanion during the fourth quarter worth about $31,398,000.

About Trupanion

Trupanion, Inc, together with its subsidiaries, provides medical insurance for cats and dogs on a monthly subscription basis in the United States, Canada, Continental Europe, and Australia. The company operates in two segments, Subscription Business and Other Business. It serves pet owners and veterinarians.